AI-generated analysis. Always verify with the original filing.
LeonaBio, Inc. stockholders approved at a Special Meeting the 2026 Equity Incentive Plan reserving up to 5,700,000 shares (plus up to 1,300,000 recycled from the 2020 Plan, which terminated for future grants), issuances of common stock upon exercises of pre-funded warrants by Sermonix Pharmaceuticals, Inc. and warrants by Perceptive Advisors LLC, and an amendment increasing authorized common shares from 90,000,000 to 400,000,000. The Certificate of Amendment was filed March 18, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Company’s
Submission of Matters to a Vote of Security Holders. The following sets forth the final results of the voting at the Special Meeting, as certified by the indepe
Other Events. The Board previously approved, subject to stockholder approval, an amendment to the Company’s Amended and Restated Certificate of Incorporation to
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation o